Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes

Christine Clar, James Alexander Gill, Rachel Court, Norman Waugh

BMJ Open · 2012 · 278 citations · 14 references

DOIFull text

Open access

Abstract

Dapagliflozin appears effective in reducing HbA1c and weight in type 2 diabetes, although more safety data are needed.

References

14